Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
3.450
-0.060 (-1.71%)
At close: Oct 2, 2026, 4:00 PM EDT
3.450
0.00 (0.00%)
After-hours: Oct 2, 2026, 4:10 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $6.65 million as of October 2, 2026. Its market cap has decreased by -38.83% in one year.
Market Cap
6.65M
Enterprise Value
10.67M
1-Year Change
-38.83%
Ranking
Category
Stock Price
$3.45
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $6.65M, a decrease of -99.04%. That is a compound annual growth rate of -55.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 6.65M | -36.68% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 7.45M |
| Skye Bioscience | 7.44M |
| NeuroSense Therapeutics | 7.27M |
| Imunon | 7.18M |
| Acurx Pharmaceuticals | 6.69M |
| Enveric Biosciences | 6.62M |
| Alzamend Neuro | 6.61M |
| CollPlant Biotechnologies | 6.54M |